Tsuneo Shimokawa

Prospective evaluation of the G8 screening tool for prognostication of survival in elderly patients with lung cancer: A single-institution study

Yoko Agemi, Tsuneo Shimokawa, Jiichiro Sasaki et al. · PLoS ONE · 2019 · 60 citations · Full text

Medicine, Geriatric Medicine, Oncology +17

S-1 is an active anticancer agent for advanced thymic carcinoma

Yusuke Okuma, Tsuneo Shimokawa, Yusuke Takagi et al. · Lung Cancer · 2010 · 35 citations

Medicine, Oncology, Pharmacology +9

A Randomized Comparison of Nivolumab versus Nivolumab + Docetaxel for Previously Treated Advanced or Recurrent ICI-Naïve Non–Small Cell Lung Cancer: TORG1630

Yuri Taniguchi, Tsuneo Shimokawa, Yuichi Takiguchi et al. · Clinical Cancer Research · 2022 · 25 citations · Full text

Medicine, Oncology, Pharmacology +17

Randomized phase II trial of S‐1 plus cisplatin or docetaxel plus cisplatin with concurrent thoracic radiotherapy for inoperable stage III non‐small cell lung cancer

Tsuneo Shimokawa, Kazuhiko Yamada, Hiroshi Tanaka et al. · Cancer Medicine · 2020 · 22 citations · Full text

Medicine, Oncology, Radiation Oncology +12

A Prospective Study of Shortened Vitamin Supplementation Prior to Cisplatin–Pemetrexed Therapy for Non-Small Cell Lung Cancer

Yusuke Takagi, Yukio Hosomi, Kuniko Sunami et al. · The Oncologist · 2014 · 19 citations · Full text

Pharmacy, Oncology, Pharmacology +17